{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:28:20Z","timestamp":1790872100501,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1038\/ncpneph0151","type":"journal-article","created":{"date-parts":[[2006,5,16]],"date-time":"2006-05-16T16:47:18Z","timestamp":1147798038000},"page":"198-208","source":"Crossref","is-referenced-by-count":160,"title":["Primary aldosteronism: diagnostic and treatment strategies"],"prefix":"10.1038","volume":"2","author":[{"given":"Cecilia","family":"Mattsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"William F","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpneph0151_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/jama.290.2.199","volume":"290","author":"I Hajjar","year":"2003","unstructured":"Hajjar I and Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988\u20132000. JAMA 290: 199\u2013206","journal-title":"JAMA"},{"key":"BFncpneph0151_CR2","first-page":"3","volume":"45","author":"JW Conn","year":"1955","unstructured":"Conn JW (1955) Presidental address: part I painting background; part II primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45: 3\u201317","journal-title":"J Lab Clin Med"},{"key":"BFncpneph0151_CR3","first-page":"389","volume":"17","author":"JW Conn","year":"1961","unstructured":"Conn JW and Conn ES (1961) Primary aldosteronism versus hypertensive disease with secondary aldosteronism. Recent Prog Horm Res 17: 389\u2013414","journal-title":"Recent Prog Horm Res"},{"key":"BFncpneph0151_CR4","first-page":"257","volume":"62","author":"JW Conn","year":"1966","unstructured":"Conn JW (1966) The evolution of primary aldosteronism: 1954\u20131967. Harvey Lect 62: 257\u2013291","journal-title":"Harvey Lect"},{"key":"BFncpneph0151_CR5","first-page":"187","volume":"2","author":"GS Andersen","year":"1988","unstructured":"Andersen GS et al. (1988) The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977\u20131981. J Hum Hypertens 2: 187\u2013189","journal-title":"J Hum Hypertens"},{"key":"BFncpneph0151_CR6","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/bmj.2.6035.554","volume":"2","author":"G Berglund","year":"1976","unstructured":"Berglund G et al. (1976) Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J 2: 554\u2013556","journal-title":"Br Med J"},{"key":"BFncpneph0151_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/jama.1968.03140330039007","volume":"205","author":"LM Fishman","year":"1968","unstructured":"Fishman LM et al. (1968) Incidence of primary aldosteronism uncomplicated \u201cessential\u201d hypertension: a prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria. JAMA 205: 497\u2013502","journal-title":"JAMA"},{"key":"BFncpneph0151_CR8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/0002-9343(79)90786-1","volume":"67","author":"DH Streeten","year":"1979","unstructured":"Streeten DH et al. (1979) Reliability of screening methods for the diagnosis of primary aldosteronism. Am J Med 67: 403\u2013413","journal-title":"Am J Med"},{"key":"BFncpneph0151_CR9","first-page":"549","volume":"52","author":"RM Tucker","year":"1977","unstructured":"Tucker RM and Labarthe DR (1977) Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from 1973 through 1975. Mayo Clin Proc 52: 549\u2013545","journal-title":"Mayo Clin Proc"},{"key":"BFncpneph0151_CR10","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.7326\/0003-4819-66-6-1079","volume":"66","author":"NM Kaplan","year":"1967","unstructured":"Kaplan NM (1967) Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism. Ann Intern Med 66: 1079\u20131090","journal-title":"Ann Intern Med"},{"key":"BFncpneph0151_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1445-5994.1976.tb03306.x","volume":"6","author":"PJ Dunn","year":"1976","unstructured":"Dunn PJ and Espiner EA (1976) Outpatient screening tests for primary aldosteronism. Aust NZ J Med 6: 131\u2013135","journal-title":"Aust NZ J Med"},{"key":"BFncpneph0151_CR12","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","volume":"141","author":"K Hiramatsu","year":"1981","unstructured":"Hiramatsu K et al. (1981) A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: results in hypertensive patients. Arch Intern Med 141: 1589\u20131593","journal-title":"Arch Intern Med"},{"key":"BFncpneph0151_CR13","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero P et al. (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89: 1045\u20131050","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpneph0151_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","volume":"42","author":"L Mosso","year":"2003","unstructured":"Mosso L et al. (2003) Primary aldosteronism and hypertensive disease. Hypertension 42: 161\u2013165","journal-title":"Hypertension"},{"key":"BFncpneph0151_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","volume":"21","author":"RD Gordon","year":"1994","unstructured":"Gordon RD et al. (1994) High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21: 315\u2013318","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFncpneph0151_CR16","first-page":"2854","volume":"85","author":"KC Loh","year":"2000","unstructured":"Loh KC et al. (2000) Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 85: 2854\u20132859","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpneph0151_CR17","first-page":"1863","volume":"85","author":"CE Fardella","year":"2000","unstructured":"Fardella CE et al. (2000) Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 85: 1863\u20131867","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpneph0151_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","volume":"14","author":"PO Lim","year":"2000","unstructured":"Lim PO et al. (2000) High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 14: 311\u2013315","journal-title":"J Hum Hypertens"},{"key":"BFncpneph0151_CR19","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1373\/clinchem.2004.041780","volume":"51","author":"GL Schwartz","year":"2005","unstructured":"Schwartz GL and Turner ST (2005) Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem 51: 386\u2013394","journal-title":"Clin Chem"},{"key":"BFncpneph0151_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1440-1681.1985.tb02641.x","volume":"12","author":"SM Hamlet","year":"1985","unstructured":"Hamlet SM et al. (1985) Is aldosterone\/renin ratio useful to screen a hypertensive population for primary aldosteronism? Clin Exp Pharmacol Physiol 12: 249\u2013252","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"BFncpneph0151_CR21","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","volume":"40","author":"DA Calhoun","year":"2002","unstructured":"Calhoun DA et al. (2002) Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40: 892\u2013896","journal-title":"Hypertension"},{"key":"BFncpneph0151_CR22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","volume":"37","author":"BJ Gallay","year":"2001","unstructured":"Gallay BJ et al. (2001) Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone\u2013renin ratio. Am J Kidney Dis 37: 699\u2013705","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph0151_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/01.HYP.34.2.315","volume":"34","author":"JH Pratt","year":"1999","unstructured":"Pratt JH et al. (1999) Levels of mineralocorticoids in whites and blacks. Hypertension 34: 315\u2013319","journal-title":"Hypertension"},{"key":"BFncpneph0151_CR24","first-page":"594","volume":"91","author":"BL Rayner","year":"2001","unstructured":"Rayner BL et al. (2001) Screening for primary aldosteronism\u2014normal ranges for aldosterone and renin in three South African population groups. S Afr Med J 91: 594\u2013599","journal-title":"S Afr Med J"},{"key":"BFncpneph0151_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1001\/jama.1965.03090030022005","volume":"193","author":"JW Conn","year":"1965","unstructured":"Conn JW et al. (1965) Normokalemic primary aldosteronism: a detectable cause of curable \u201cessential\u201d hypertension. JAMA 193: 200\u2013206","journal-title":"JAMA"},{"key":"BFncpneph0151_CR26","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","volume":"40","author":"P Mulatero","year":"2002","unstructured":"Mulatero P et al. (2002) Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism. Hypertension 40: 897\u2013902","journal-title":"Hypertension"},{"key":"BFncpneph0151_CR27","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0895-7061(02)02969-2","volume":"15","author":"E Rossi","year":"2002","unstructured":"Rossi E et al. (2002) High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens 15: 896\u2013902","journal-title":"Am J Hypertens"},{"key":"BFncpneph0151_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/01.mnh.0000165889.60254.98","volume":"14","author":"NJ Brown","year":"2005","unstructured":"Brown NJ (2005) Aldosterone and end-organ damage. Curr Opin Nephrol Hypertens 14: 235\u2013241","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"BFncpneph0151_CR29","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","volume":"67","author":"CG Brilla","year":"1990","unstructured":"Brilla CG et al. (1990) Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 67: 1355\u20131364","journal-title":"Circ Res"},{"key":"BFncpneph0151_CR30","doi-asserted-by":"publisher","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","volume":"283","author":"R Rocha","year":"2002","unstructured":"Rocha R et al. (2002) Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol 283: H1802\u20131810","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFncpneph0151_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/00004872-200103001-00017","volume":"19","author":"Y Takeda","year":"2001","unstructured":"Takeda Y et al. (2001) Effects of high sodium intake on cardiovascular aldosterone synthesis in stroke-prone spontaneously hypertensive rats. J Hypertens 19: 635\u2013639","journal-title":"J Hypertens"},{"key":"BFncpneph0151_CR32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/01.HYP.0000052542.68896.2B","volume":"41","author":"M Kozakova","year":"2003","unstructured":"Kozakova M et al. (2003) Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin. Hypertension 41: 230\u2013236","journal-title":"Hypertension"},{"key":"BFncpneph0151_CR33","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1210\/jc.2005-0681","volume":"90","author":"M Stowasser","year":"2005","unstructured":"Stowasser M et al. (2005) Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab 90: 5070\u20135076","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpneph0151_CR34","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P et al. (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45: 1243\u20131248","journal-title":"J Am Coll Cardiol"},{"key":"BFncpneph0151_CR35","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B et al. (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348: 1309\u20131321","journal-title":"N Engl J Med"},{"key":"BFncpneph0151_CR36","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","volume":"102","author":"F Zannad","year":"2000","unstructured":"Zannad F et al. (2000) Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the Randomized Aldactone Evaluation Study (RALES). Circulation 102: 2700\u20132706","journal-title":"Circulation"},{"key":"BFncpneph0151_CR37","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1210\/jc.2005-1733","volume":"91","author":"F Fallo","year":"2006","unstructured":"Fallo F et al. (2006) Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 91: 454\u2013459","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpneph0151_CR38","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1161\/01.CIR.0000155621.10213.06","volume":"111","author":"VS Chhokar","year":"2005","unstructured":"Chhokar VS et al. (2005) Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 111: 871\u2013878","journal-title":"Circulation"},{"key":"BFncpneph0151_CR39","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1210\/en.2003-0279","volume":"144","author":"WF Young Jr","year":"2003","unstructured":"Young WF Jr (2003) Minireview: primary aldosteronism\u2014changing concepts in diagnosis and treatment. Endocrinology 144: 2208\u20132213","journal-title":"Endocrinology"},{"key":"BFncpneph0151_CR40","doi-asserted-by":"publisher","first-page":"877","DOI":"10.7326\/0003-4819-121-11-199412010-00010","volume":"121","author":"JD Blumenfeld","year":"1994","unstructured":"Blumenfeld JD et al. (1994) Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 121: 877\u2013885","journal-title":"Ann Intern Med"},{"key":"BFncpneph0151_CR41","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0895-7061(01)02312-3","volume":"15","author":"GA Mansoor","year":"2002","unstructured":"Mansoor GA et al. (2002) Unilateral adrenal hyperplasia causing primary aldosteronism: limitations of I-131 norcholesterol scanning. Am J Hypertens 15: 459\u2013464","journal-title":"Am J Hypertens"},{"key":"BFncpneph0151_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1677\/erc.1.00867","volume":"12","author":"TM Seccia","year":"2005","unstructured":"Seccia TM et al. (2005) Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course. Endocr Relat Cancer 12: 149\u2013159","journal-title":"Endocr Relat Cancer"},{"key":"BFncpneph0151_CR43","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/00004872-200404000-00001","volume":"22","author":"P Mulatero","year":"2004","unstructured":"Mulatero P et al. (2004) Genetics of primary aldosteronism. J Hypertens 22: 663\u2013670","journal-title":"J Hypertens"},{"key":"BFncpneph0151_CR44","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1097\/01.hjh.0000174299.66369.26","volume":"23","author":"A So","year":"2005","unstructured":"So A et al. (2005) Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity. J Hypertens 23: 1477\u20131484","journal-title":"J Hypertens"},{"issue":"Suppl A","key":"BFncpneph0151_CR45","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1016\/S1096-6374(03)00064-9","volume":"13","author":"WF Young Jr","year":"2003","unstructured":"Young WF Jr (2003) Primary aldosteronism\u2014treatment options. Growth Horm IGF Res 13 (Suppl A): S102\u2013S108","journal-title":"Growth Horm IGF Res"},{"key":"BFncpneph0151_CR46","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0025-6196(11)62105-8","volume":"76","author":"VM Montori","year":"2001","unstructured":"Montori VM et al. (2001) Validity of the aldosterone\u2013renin ratio used to screen for primary aldosteronism. Mayo Clin Proc 76: 877\u2013882","journal-title":"Mayo Clin Proc"},{"key":"BFncpneph0151_CR47","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/00004872-200405000-00001","volume":"22","author":"NM Kaplan","year":"2004","unstructured":"Kaplan NM (2004) The current epidemic of primary aldosteronism: causes and consequences. J Hypertens 22: 863\u2013869","journal-title":"J Hypertens"},{"key":"BFncpneph0151_CR48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.amjhyper.2004.08.025","volume":"18","author":"M Lamarre-Cliche","year":"2005","unstructured":"Lamarre-Cliche M et al. (2005) Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives. Am J Hypertens 18: 56\u201364","journal-title":"Am J Hypertens"},{"key":"BFncpneph0151_CR49","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1210\/jcem.86.9.7867","volume":"86","author":"D Hirohara","year":"2001","unstructured":"Hirohara D et al. (2001) Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives. J Clin Endocrinol Metab 86: 4292\u20134298","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpneph0151_CR50","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0889-8529(02)00013-0","volume":"31","author":"VM Montori","year":"2002","unstructured":"Montori VM and Young WF Jr (2002) Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism: a systematic review of the literature. Endocrinol Metab Clin North Am 31: 619\u2013632","journal-title":"Endocrinol Metab Clin North Am"},{"key":"BFncpneph0151_CR51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1210\/jc.2004-1149","volume":"90","author":"SC Tiu","year":"2005","unstructured":"Tiu SC et al. (2005) The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 90: 72\u201378","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpneph0151_CR52","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1001\/archinte.1993.00410180075008","volume":"153","author":"MH Weinberger","year":"1993","unstructured":"Weinberger MH and Fineberg NS (1993) The diagnosis of primary aldosteronism and separation of two major subtypes. Arch Intern Med 153: 2125\u20132129","journal-title":"Arch Intern Med"},{"key":"BFncpneph0151_CR53","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1530\/eje.0.1500517","volume":"150","author":"N Unger","year":"2004","unstructured":"Unger N et al. (2004) Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass. Eur J Endocrinol 150: 517\u2013523","journal-title":"Eur J Endocrinol"},{"key":"BFncpneph0151_CR54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/00004872-200402000-00023","volume":"22","author":"P Ferrari","year":"2004","unstructured":"Ferrari P et al. (2004) Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism. J Hypertens 22: 377\u2013381","journal-title":"J Hypertens"},{"key":"BFncpneph0151_CR55","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1210\/jc.2003-032179","volume":"89","author":"O Olivieri","year":"2004","unstructured":"Olivieri O et al. (2004) Aldosterone to renin ratio in a primary care setting: the Bussolengo study. J Clin Endocrinol Metab 89: 4221\u20134226","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpneph0151_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","volume":"217","author":"M Stowasser","year":"2004","unstructured":"Stowasser M and Gordon RD (2004) Primary aldosteronism\u2014careful investigation is essential and rewarding. Mol Cell Endocrinol 217: 33\u201339","journal-title":"Mol Cell Endocrinol"},{"key":"BFncpneph0151_CR57","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1161\/01.HYP.37.3.856","volume":"37","author":"PO Lim","year":"2001","unstructured":"Lim PO et al. (2001) Adverse cardiac effects of salt with fludrocortisone in hypertension. Hypertension 37: 856\u2013861","journal-title":"Hypertension"},{"key":"BFncpneph0151_CR58","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0889-8529(18)30425-0","volume":"17","author":"WF Young Jr","year":"1988","unstructured":"Young WF Jr and Klee GG (1988) Primary aldosteronism: diagnostic evaluation. Endocrinol Metab Clin North Am 17: 367\u2013395","journal-title":"Endocrinol Metab Clin North Am"},{"key":"BFncpneph0151_CR59","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1161\/01.HYP.37.6.1440","volume":"37","author":"M Agharazii","year":"2001","unstructured":"Agharazii M et al. (2001) Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 37: 1440\u20131443","journal-title":"Hypertension"},{"key":"BFncpneph0151_CR60","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/00001622-200301000-00013","volume":"15","author":"GB Thompson","year":"2003","unstructured":"Thompson GB and Young WF Jr (2003) Adrenal incidentaloma. Curr Opin Oncol 15: 84\u201390","journal-title":"Curr Opin Oncol"},{"key":"BFncpneph0151_CR61","first-page":"460","volume":"16","author":"RT Kloos","year":"1995","unstructured":"Kloos RT et al. (1995) Incidentally discovered adrenal masses. Endocr Rev 16: 460\u2013484","journal-title":"Endocr Rev"},{"key":"BFncpneph0151_CR62","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","volume":"136","author":"WF Young","year":"2004","unstructured":"Young WF et al. (2004) Role for adrenal venous sampling in primary aldosteronism. Surgery 136: 1227\u20131235","journal-title":"Surgery"},{"key":"BFncpneph0151_CR63","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/00006231-200306000-00011","volume":"24","author":"F Lumachi","year":"2003","unstructured":"Lumachi F et al. (2003) Non-invasive adrenal imaging in primary aldosteronism: sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI. Nucl Med Commun 24: 683\u2013688","journal-title":"Nucl Med Commun"},{"key":"BFncpneph0151_CR64","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1056\/NEJM197602192940802","volume":"294","author":"MJ Hogan","year":"1976","unstructured":"Hogan MJ et al. (1976) Location of aldosterone-producing adenomas with 131I-19-iodocholesterol. N Engl J Med 294: 410\u2013414","journal-title":"N Engl J Med"},{"key":"BFncpneph0151_CR65","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1210\/jcem-71-4-825","volume":"71","author":"K Nomura","year":"1990","unstructured":"Nomura K et al. (1990) Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: relationship to adenoma size and functional activity. J Clin Endocrinol Metab 71: 825\u2013830","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpneph0151_CR66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s003450050022","volume":"16","author":"PL Choyke","year":"1998","unstructured":"Choyke PL (1998) From needles to numbers: can noninvasive imaging distinguish benign and malignant adrenal lesions? World J Urol 16: 29\u201334","journal-title":"World J Urol"},{"key":"BFncpneph0151_CR67","doi-asserted-by":"publisher","first-page":"157","DOI":"10.7326\/0003-4819-138-2-200301210-00024","volume":"138","author":"WF Young Jr","year":"2003","unstructured":"Young WF Jr et al. (2003) Adrenalectomy for primary aldosteronism; authors' reply. Ann Intern Med 138: 157\u2013159","journal-title":"Ann Intern Med"},{"key":"BFncpneph0151_CR68","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1161\/01.HYP.31.1.445","volume":"31","author":"WR Litchfield","year":"1998","unstructured":"Litchfield WR et al. (1998) Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31: 445\u2013450","journal-title":"Hypertension"},{"key":"BFncpneph0151_CR69","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0960-0760(01)00097-8","volume":"78","author":"M Stowasser","year":"2001","unstructured":"Stowasser M and Gordon RD (2001) Familial hyperaldosteronism. J Steroid Biochem Mol Biol 78: 215\u2013229","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BFncpneph0151_CR70","doi-asserted-by":"publisher","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","volume":"135","author":"AM Sawka","year":"2001","unstructured":"Sawka AM et al. (2001) Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 135: 258\u2013261","journal-title":"Ann Intern Med"},{"key":"BFncpneph0151_CR71","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1046\/j.1365-2168.2002.02261.x","volume":"89","author":"M Sywak","year":"2002","unstructured":"Sywak M and Pasieka JL (2002) Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg 89: 1587\u20131593","journal-title":"Br J Surg"},{"key":"BFncpneph0151_CR72","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00268-004-7496-z","volume":"29","author":"A Meyer","year":"2005","unstructured":"Meyer A et al. (2005) Long-term follow-up after adrenalectomy for primary aldosteronism. World J Surg 29: 155\u2013159","journal-title":"World J Surg"},{"key":"BFncpneph0151_CR73","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1001\/archsurg.1996.01430180072015","volume":"131","author":"O Celen","year":"1996","unstructured":"Celen O et al. (1996) Factors influencing outcome of surgery for primary aldosteronism. Arch Surg 131: 646\u2013650","journal-title":"Arch Surg"},{"key":"BFncpneph0151_CR74","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/00000658-199608000-00003","volume":"224","author":"CY Lo","year":"1996","unstructured":"Lo CY et al. (1996) Primary aldosteronism: results of surgical treatment. Ann Surg 224: 125\u2013130","journal-title":"Ann Surg"},{"key":"BFncpneph0151_CR75","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1067\/msy.1998.93108","volume":"124","author":"CA Proye","year":"1998","unstructured":"Proye CA et al. (1998) Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism? Surgery 124: 1128\u20131133","journal-title":"Surgery"},{"key":"BFncpneph0151_CR76","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/sj.jhh.1001644","volume":"18","author":"T Zelinka","year":"2004","unstructured":"Zelinka T et al. (2004) Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome. J Hum Hypertens 18: 107\u2013111","journal-title":"J Hum Hypertens"},{"key":"BFncpneph0151_CR77","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/bjs.4738","volume":"91","author":"A Assalia","year":"2004","unstructured":"Assalia A and Gagner M (2004) Laparoscopic adrenalectomy. Br J Surg 91: 1259\u20131274","journal-title":"Br J Surg"},{"key":"BFncpneph0151_CR78","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/000313480206800307","volume":"68","author":"H Rossi","year":"2002","unstructured":"Rossi H et al. (2002) Primary hyperaldosteronism in the era of laparoscopic adrenalectomy. Am Surg 68: 253\u2013256","journal-title":"Am Surg"},{"key":"BFncpneph0151_CR79","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/000313480407000803","volume":"70","author":"R Gonzalez","year":"2004","unstructured":"Gonzalez R et al. (2004) Laparoscopic approach reduces likelihood of perioperative complications in patients undergoing adrenalectomy. Am Surg 70: 668\u2013674","journal-title":"Am Surg"},{"key":"BFncpneph0151_CR80","first-page":"1995","volume":"10","author":"NE Jacobsen","year":"2003","unstructured":"Jacobsen NE et al. (2003) Laparoscopic versus open adrenalectomy for surgical adrenal disease. Can J Urol 10: 1995\u20131999","journal-title":"Can J Urol"},{"key":"BFncpneph0151_CR81","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.amjsurg.2005.02.003","volume":"189","author":"J Chavez-Rodriguez","year":"2005","unstructured":"Chavez-Rodriguez J and Pasieka JL (2005) Adrenal lesions assessed in the era of laparoscopic adrenalectomy: a modern day series. Am J Surg 189: 581\u2013585","journal-title":"Am J Surg"},{"key":"BFncpneph0151_CR82","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00268-004-7619-6","volume":"28","author":"BD Saunders","year":"2004","unstructured":"Saunders BD et al. (2004) Trends in utilization of adrenalectomy in the United States: have indications changed? World J Surg 28: 1169\u20131175","journal-title":"World J Surg"},{"key":"BFncpneph0151_CR83","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/01.ju.0000162045.68387.c3","volume":"174","author":"S Ishidoya","year":"2005","unstructured":"Ishidoya S et al. (2005) Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol 174: 40\u201343","journal-title":"J Urol"},{"key":"BFncpneph0151_CR84","doi-asserted-by":"publisher","first-page":"105","DOI":"10.7326\/0003-4819-131-2-199907200-00005","volume":"131","author":"RP Ghose","year":"1999","unstructured":"Ghose RP et al. (1999) Medical management of aldosterone-producing adenomas. Ann Intern Med 131: 105\u2013108","journal-title":"Ann Intern Med"},{"key":"BFncpneph0151_CR85","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","volume":"60","author":"X Jeunemaitre","year":"1987","unstructured":"Jeunemaitre X et al. (1987) Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol 60: 820\u2013825","journal-title":"Am J Cardiol"},{"key":"BFncpneph0151_CR86","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10741-005-2345-1","volume":"10","author":"DA Sica","year":"2005","unstructured":"Sica DA (2005) Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis. Heart Fail Rev 10: 23\u201329","journal-title":"Heart Fail Rev"},{"key":"BFncpneph0151_CR87","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","volume":"15","author":"MH Weinberger","year":"2002","unstructured":"Weinberger MH et al. (2002) Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension. Am J Hypertens 15: 709\u2013716","journal-title":"Am J Hypertens"},{"key":"BFncpneph0151_CR88","first-page":"438","volume-title":"Red Book: Pharmacy's Fundamental Reference","author":"T Fleming","year":"2005","unstructured":"Fleming T (Ed.; 2005) Red Book: Pharmacy's Fundamental Reference, 438 and 614. Montvale: Thomson PDR"},{"key":"BFncpneph0151_CR89","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1161\/01.HYP.0000123572.45556.a5","volume":"43","author":"H Oberleithner","year":"2004","unstructured":"Oberleithner H et al. (2004) Human endothelium: target for aldosterone. Hypertension 43: 952\u2013956","journal-title":"Hypertension"},{"key":"BFncpneph0151_CR90","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/ajh\/6.6.487","volume":"6","author":"SE Campbell","year":"1993","unstructured":"Campbell SE et al. (1993) Myocardial fibrosis in the rat with mineralocorticoid excess: prevention of scarring by amiloride. Am J Hypertens 6: 487\u2013495","journal-title":"Am J Hypertens"},{"key":"BFncpneph0151_CR91","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1210\/jcem.84.12.6256","volume":"84","author":"RG Dluhy","year":"1999","unstructured":"Dluhy RG and Lifton RP (1999) Glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 84: 4341\u20134344","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Nature Clinical Practice Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0151","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpneph0151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph0151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:12:15Z","timestamp":1684440735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneph0151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["BFncpneph0151"],"URL":"https:\/\/doi.org\/10.1038\/ncpneph0151","relation":{},"ISSN":["1745-8323","1745-8331"],"issn-type":[{"value":"1745-8323","type":"print"},{"value":"1745-8331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}